We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
NitricBio Selects Clinipace Worldwide to Manage Multiple Clinical Trials
News

NitricBio Selects Clinipace Worldwide to Manage Multiple Clinical Trials

NitricBio Selects Clinipace Worldwide to Manage Multiple Clinical Trials
News

NitricBio Selects Clinipace Worldwide to Manage Multiple Clinical Trials

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "NitricBio Selects Clinipace Worldwide to Manage Multiple Clinical Trials"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Clinipace Worldwide has announced that NitricBio has selected the company to manage and deploy multiple studies in support of medical applications of topical nitric oxide gas (gNO).

“Their approach towards a fully-integrated technology-driven clinical research model will help us drive greater trial visibility, more project control, and, ultimately, lower costs for each of our four trials.”

NitricBio is a mid-stage specialty pharmaceutical company focused on the dermatology and podiatry markets, with two unique drug delivery technologies. The company awarded Clinipace Worldwide a four-project engagement, including data management, statistical services, and medical writing for two phase 2 trials as well as providing fully-integrated clinical research services to manage and conduct two phase 3 trials.

“Clinipace Worldwide offered the global experience and full-service expertise we were looking for in a CRO partner,” said Tanya Rhodes, chief technology officer, NitricBio. “Their approach towards a fully-integrated technology-driven clinical research model will help us drive greater trial visibility, more project control, and, ultimately, lower costs for each of our four trials.”

In addition to delivering clinical development services, Clinipace Worldwide will deploy its web-based technology platform to collect, manage, and monitor study data, which will greatly streamline associated processes and trial timelines for NitricBio.

“Clinipace Worldwide is committed to providing innovative companies like NitricBio with a full-range of development solutions and expert services to match any size clinical study and operational approach,” said Christopher Porter, chief operating officer, Clinipace.
Advertisement